C5a and the terminal complex can activate monocytes and neutrophils with the release of biologically active and potent inflammatory mediators such as proteases, free oxygen radicals, and pro-inflammatory cytokines (50), which hinder angiogenesis and then contribute to placental insufficiency and maternal endothelial dysfunction in patients with preeclampsia (5). The gene discussed is C5; the disease is preeclampsia.